Flowers Foods Inc
—- Market cap
- —
- Debt
- —
- Cash
- −$12.10M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: FLO stock price vs SJM: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at SJM's multiple
Needs SJM P/E.
Implied fair value · at FLO's multiple
Needs Annual EPS is negative, FLO P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Higher is better
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Ten period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
FLOWERS FOODS INC · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
The J. M. Smucker Company · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Gentherm Inc
FLO vs THRM
Post Holdings, Inc.
FLO vs POST
Zoetis Inc.
FLO vs ZTS
CONAGRA BRANDS INC.
FLO vs CAG
COCA COLA CO
FLO vs KO
PEPSICO INC
FLO vs PEP
GENERAL MILLS INC
FLO vs GIS
COLGATE PALMOLIVE CO
FLO vs CL
Lamb Weston Holdings, Inc.
FLO vs LW
HORMEL FOODS CORP /DE/
FLO vs HRL
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe FLO can sustain its positive margins and avoid a deterioration in leverage, then the relative undervaluation versus SJM supports a buy case because FLO is far cheaper on P/S, EV/Revenue, and EV/EBITDA while remaining profitable.
FLO trades at 0.3x P/S versus SJM at 1.4x, and the stated implied price from the P/S multiple is $34.61 versus FLO's current price of $7.22, implying 379.3% upside. That gap is supported by FLO's cheaper EV/Revenue and EV/EBITDA multiples, with price currently sitting at the low end of its historical band and below the DCF range.
Supporting Metrics